From the Laboratory of Genome and Biosignal, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, 192-0392 Tokyo.
From the Laboratory of Genome and Biosignal, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachioji, 192-0392 Tokyo,; PRESTO, Japan Science and Technology Agency, 4-1-8 Honcho Kawaguchi, Saitama, and.
J Biol Chem. 2011 Mar 11;286(10):8459-8471. doi: 10.1074/jbc.M110.171223. Epub 2010 Dec 27.
Phospholipase Cδ3 (PLCδ3) is a key enzyme regulating phosphoinositide metabolism; however, its physiological function remains unknown. Because PLCδ3 is highly enriched in the cerebellum and cerebral cortex, we examined the role of PLCδ3 in neuronal migration and outgrowth. PLCδ3 knockdown (KD) inhibits neurite formation of cerebellar granule cells, and application of PLCδ3KD using in utero electroporation in the developing brain results in the retardation of the radial migration of neurons in the cerebral cortex. In addition, PLCδ3KD inhibits axon and dendrite outgrowth in primary cortical neurons. PLCδ3KD also suppresses neurite formation of Neuro2a neuroblastoma cells induced by serum withdrawal or treatment with retinoic acid. This inhibition is released by the reintroduction of wild-type PLCδ3. Interestingly, the H393A mutant lacking phosphatidylinositol 4,5-bisphosphate hydrolyzing activity generates supernumerary protrusions, and a constitutively active mutant promotes extensive neurite outgrowth, indicating that PLC activity is important for normal neurite outgrowth. The introduction of dominant negative RhoA (RhoA-DN) or treatment with Y-27632, a Rho kinase-specific inhibitor, rescues the neurite extension in PLCδ3KD Neuro2a cells. Similar effects were also detected in primary cortical neurons. Furthermore, the RhoA expression level was significantly decreased by serum withdrawal or retinoic acid in control cells, although this decrease was not observed in PLCδ3KD cells. We also found that exogenous expression of PLCδ3 down-regulated RhoA protein, and constitutively active PLCδ3 promotes the RhoA down-regulation more significantly than PLCδ3 upon differentiation. These results indicate that PLCδ3 negatively regulates RhoA expression, inhibits RhoA/Rho kinase signaling, and thereby promotes neurite extension.
磷酯酶 Cδ3(PLCδ3)是一种调节磷酸肌醇代谢的关键酶;然而,其生理功能尚不清楚。由于 PLCδ3在小脑和大脑皮层中高度富集,我们研究了 PLCδ3 在神经元迁移和生长中的作用。PLCδ3 敲低(KD)抑制小脑颗粒细胞的突起形成,并且在发育中的大脑中使用体内电穿孔应用 PLCδ3KD 会导致大脑皮层神经元的放射状迁移延迟。此外,PLCδ3KD 抑制原代皮质神经元的轴突和树突生长。PLCδ3KD 还抑制血清剥夺或维甲酸处理诱导的 Neuro2a 神经母细胞瘤细胞的突起形成。这种抑制作用通过重新引入野生型 PLCδ3 得到释放。有趣的是,缺乏磷脂酰肌醇 4,5-二磷酸水解活性的 H393A 突变体产生多余的突起,而组成型激活的突变体促进广泛的突起生长,表明 PLC 活性对于正常的突起生长很重要。引入显性负性 RhoA(RhoA-DN)或 Rho 激酶特异性抑制剂 Y-27632 可挽救 PLCδ3KD Neuro2a 细胞中的突起延伸。在原代皮质神经元中也检测到类似的效果。此外,在对照细胞中,血清剥夺或维甲酸会显著降低 RhoA 的表达水平,尽管在 PLCδ3KD 细胞中未观察到这种降低。我们还发现,外源性表达 PLCδ3 下调 RhoA 蛋白,并且组成型激活的 PLCδ3 比分化时的 PLCδ3 更显著地促进 RhoA 的下调。这些结果表明 PLCδ3 负调节 RhoA 表达,抑制 RhoA/Rho 激酶信号通路,从而促进突起延伸。